INTERPHEX and the Parenteral Drug Association (PDA) have signed a three-year sponsorship agreement. This move “aligns the objectives of both organizations to service key needs of the global pharmaceutical and biopharmaceutical industry by driving innovation and advancement,” according to an INTERPHEX statement.

PDA will be directly involved in developing the INTERPHEX conference programming, identifying speakers from industry and regulatory agencies and developing a PDA-sponsored cGMP Track. PDA members will have educational and networking opportunities including an exclusive Association Membership Lounge.

“Our sponsorship of INTERPHEX reflects our support of the continued enhancement of industry learning and improvement, areas we find present at INTERPHEX,” stated Richard Johnson, president and chief executive officer of PDA. “Non-profits and corporate entities can work together to leverage best practices, in real-time, to the benefit of our industry. Our collaboration with INTERPHEX is one example of this effort and we are pleased to move forward in this shared endeavor.”

“Long-term sponsorship with PDA, both on national and global levels, aligns us with thought leaders across the globe,” said Bob Stewart, vice president of INTERPHEX. “By fostering alliances with successful non-profit organizations like PDA, we acknowledge our investment in the future of the biopharmaceutical industry, and ultimately deliver unrivaled opportunities for knowledge, interaction, and professional growth.”

INTERPHEX will be held March 18-20, 2014 at the Jacobs Javits Center in New York City, NY.